Sun Pharmaceutical Industries announces Jayashree Satagopan as incoming CFO

Jayashree brings over 30 years of experience in managing multiple portfolios, cutting across various geographies, in diverse sectors such as agri-solutions, healthcare, manufacturing, and automotive. In her last role, she was associated with Coromandel International Ltd., part of the Murugappa group, as President Corporate and Chief Financial Officer. She was also associated with PI Industries, International Paper Company, GE Healthcare, Ford India, and Ashok Leyland.

Jayashree is a Commerce Graduate from the University of Madras, and holds professional qualifications - Chartered Accountant (CA), Cost and Management Accountant (CMA), and Company Secretary (CS).

Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult-to-make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), and Intermediates.